Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

HITTING the Diagnosis: Testing for Heparin-Induced Thrombocytopenia in Cancer Patients.

Fenelus M, Peerschke EIB.

Am J Clin Pathol. 2018 Jul 3;150(2):116-120. doi: 10.1093/ajcp/aqy040.

2.

Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms.

Gao Q, Yellapantula V, Fenelus M, Pichardo J, Wang L, Landgren O, Dogan A, Roshal M.

Mod Pathol. 2018 Jun;31(6):881-889. doi: 10.1038/s41379-018-0011-0. Epub 2018 Feb 5.

3.

Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution.

Chau K, Rosen L, Coutsouvelis C, Fenelus M, Brenkert R, Klein M, Stone G, Raab S, Aziz M, Cocker R.

Cancer Cytopathol. 2015 Jan;123(1):10-8. doi: 10.1002/cncy.21477. Epub 2014 Nov 11.

4.

The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.

Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA, Matthew SM, Grin'kina N, Orynbayeva Z, Shaikh MF, Adler V, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2014 Summer;44(3):241-8.

PMID:
25117093
5.

Anti-cancer peptides from ras-p21 and p53 proteins.

Pincus MR, Fenelus M, Sarafraz-Yazdi E, Adler V, Bowne W, Michl J.

Curr Pharm Des. 2011;17(25):2677-98. Review.

PMID:
21728981

Supplemental Content

Loading ...
Support Center